pivotal
-
Alzheimer’s & Dementia Care
June: A Pivotal Month for Alzheimer’s and Brain Awareness, Catalyzing Research and Action Against a Global Health Challenge
June marks a critical period for global public health as the Alzheimer’s Association spearheads Alzheimer’s & Brain Awareness Month, a…
Read More » -
Alzheimer’s & Dementia Care
Health Canada Conditionally Approves Leqembi, Marking a Pivotal Shift in Alzheimer’s Treatment by Targeting Underlying Disease Cause
Health Canada has granted conditional approval for Leqembi (lecanemab), a groundbreaking therapy co-developed by Eisai and Biogen, for specific adults…
Read More » -
Alzheimer’s & Dementia Care
Semaglutide Fails to Slow Alzheimer’s Progression in Pivotal Phase 3 Trials, Halting Further Development for the Condition.
Semaglutide, an anti-diabetic medication widely known under brand names like Ozempic, Rybelsus, and Wegovy, did not demonstrate a statistically significant…
Read More »
